Insights from David Budd, CEO of genedrive, on the advances in pharmacogenetic testing technology to maintain quality of care and treatment optimisation in acute medical settings.
Image
Pharmacogenetic testing is increasingly recognised as a key tool in the future of personalised medicine, as it enables clinicians to identify those in whom certain drugs are ineffective, or worse, harmful. Armed with information about the genetic profiles of their patients, oncologists have, for years, been able to deliver customised treatment strategies, giving patients the correct dose of the correct medication at the correct time.